Please provide your email address to receive an email when new articles are posted on . FRANKFURT, Germany — The ICL allows for reliable, predictable correction of low to high degrees of myopia with ...

Please provide your email address to receive an email when new articles are posted on . Bell reported results from the phase 3 CHAMP clinical study, which evaluated children with –0.5 D to –6 D ...

Childhood myopia progression could be treated with low-dose atropine due to the safety and efficacy displayed in this study. The global prevalence of myopia was estimated to be 30% to 34% in 2020 and ...

Myopia, or nearsightedness, is at an all-time high among children in the US. Globally, half the population is expected to be nearsighted by 2050. Ophthalmologists are gravely concerned that these ...

Use of low-dose atropine eyedrops (concentration 0.01%) was no better than placebo at slowing myopia (nearsightedness) progression and elongation of the eye among children treated for two years, ...

Myopia affects roughly one third of the population worldwide ― a figure that is projected to reach 50% by 2050. Low-dose atropine, which helps curb the condition, currently is available in the United ...

Treating U.S. children with an investigational low-dose (0.01%) formulation of atropine eye drops didn't delay worsening of nearsightedness, a randomized clinical trial found. Over 24 months, kids ...

Share on Pinterest Experts say the incidence of nearsightedness in children is rising. Catherine Falls Commercial/Getty Images Experts say that developing nearsightedness as a child might be an ...

A study conducted at Vanderbilt University Medical Center and 11 other hospitals and practices across the United States shows that use of low-dose atropine eyedrops, commonly used in a higher dose to ...

As myopia rates climb, eyecare experts are urging clinicians to take frontline action and get ahead of the condition before it escalates to something worse. “It is a serious visual disease that ...